DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$82.52+0.48 (+0.59%)
Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –
DexCom pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
DexCom's pe ratio was 31.9× on Nov 11, 2026, against 35.5× a year earlier. Over the last 5 years it ranged from 28.5× to 241.3×, with a median of 77.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 31.9× | −5.2 |
| 2025 | Dec 31, 2025 | 37.1× | −9.8 |
| 2024 | Dec 31, 2024 | 46.8× | −89.5 |
| 2023 | Dec 29, 2023 | 136.4× | −58.9 |
| 2022 | Dec 30, 2022 | 195.2× | +94.3 |
| 2021 | Dec 31, 2021 | 100.9× | −51.8 |
| 2020 | Dec 31, 2020 | 152.8× | −147.3 |
| 2019 | Jan 31, 2019 | 300.1× | +45.2 |
| 2018 | Dec 31, 2018 | 254.9× | – |
See a number that looks wrong?